Virta was selected by CMS as

This matters because CMS is turning Virta from a benefit sold mostly to employers into a product that could plug into the public payer stack. The early adopter role is not just a logo partnership. It requires Virta to connect its app to CMS aligned data networks, use claims and clinical history with patient consent, and show working progress by early 2026, which is the practical path to serving Medicare and Medicaid members at scale.

• Virta already has the operating model for high cost metabolic patients. It sells diabetes reversal into health plans and self insured employers, using connected devices, frequent coach check ins, and physician oversight. That makes CMS fit especially important because diabetes and obesity are common in older and lower income populations, not just employer populations.
  4 sacra 5 sacra 6 cdc
• The CMS category is built around personalized support from real clinical records, not generic wellness content. Early adopters in Virta’s pillar include Noom, Oura, Welldoc, Teladoc Health, and Vida Health, which shows CMS is assembling an app layer for chronic disease management where interoperability becomes part of product distribution.
  2 cms 3 virtahealth
• Virta’s wedge with government payers is cost control. Its obesity program is positioned as a lower cost alternative to GLP-1 drug spend, while its diabetes program is sold on outcomes and savings. That value story becomes more compelling in Medicare and Medicaid, where a small reduction in admissions, insulin use, or drug costs can matter across huge member bases.
  4 sacra 8 cms

By early 2026, the winners in metabolic care will look less like standalone telehealth brands and more like connected infrastructure inside payer workflows. If Virta can turn CMS integration into live government contracts, it expands from a few hundred employer and plan customers into a much larger channel where diabetes and obesity management budgets are structurally rising.